- Home
- FRAF vs NYXH Comparison
FRAF vs NYXH Comparison
Compare FRAF & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRAF
- NYXH
- Stock Information
- Founded
- FRAF 1906
- NYXH 2009
- Country
- FRAF United States
- NYXH Belgium
- Employees
- FRAF N/A
- NYXH N/A
- Industry
- FRAF Major Banks
- NYXH Medical/Dental Instruments
- Sector
- FRAF Finance
- NYXH Health Care
- Exchange
- FRAF Nasdaq
- NYXH Nasdaq
- Market Cap
- FRAF 212.1M
- NYXH 185.5M
- IPO Year
- FRAF N/A
- NYXH 2021
- Fundamental
- Price
- FRAF $45.43
- NYXH $4.95
- Analyst Decision
- FRAF
- NYXH Strong Buy
- Analyst Count
- FRAF 0
- NYXH 3
- Target Price
- FRAF N/A
- NYXH $15.00
- AVG Volume (30 Days)
- FRAF 17.1K
- NYXH 66.3K
- Earning Date
- FRAF 10-21-2025
- NYXH 11-05-2025
- Dividend Yield
- FRAF 2.91%
- NYXH N/A
- EPS Growth
- FRAF 5.82
- NYXH N/A
- EPS
- FRAF 3.29
- NYXH N/A
- Revenue
- FRAF $74,998,000.00
- NYXH $5,793,306.00
- Revenue This Year
- FRAF N/A
- NYXH $85.62
- Revenue Next Year
- FRAF N/A
- NYXH $320.09
- P/E Ratio
- FRAF $13.81
- NYXH N/A
- Revenue Growth
- FRAF 8.15
- NYXH 2.94
- 52 Week Low
- FRAF $28.01
- NYXH $4.35
- 52 Week High
- FRAF $49.42
- NYXH $11.87
- Technical
- Relative Strength Index (RSI)
- FRAF 41.37
- NYXH 42.30
- Support Level
- FRAF $44.90
- NYXH $4.35
- Resistance Level
- FRAF $48.60
- NYXH $5.13
- Average True Range (ATR)
- FRAF 0.69
- NYXH 0.24
- MACD
- FRAF -0.59
- NYXH 0.09
- Stochastic Oscillator
- FRAF 11.73
- NYXH 67.60
About FRAF Franklin Financial Services Corporation
Franklin Financial Services Corp is a bank holding company based in the United States. It is engaged in general commercial, retail banking and trust services normally associated with community banks. It offers a broad range of banking services to businesses, individuals and governmental entities which includes accepting and maintaining cheques, savings, and time deposit accounts, providing investment and trust services, making loans and providing safe deposit facilities. The bank also performs personal, corporate, pension and fiduciary services through its Investment and Trust Services Department.
About NYXH Nyxoah SA
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.